Daily Sepsis Research Analysis

Using co-incubated human erythrocytes and platelets, murine blood, and intravenous histone administration in mice, the study found that histones increased platelet–erythrocyte complex formation approximately tenfold. Histone-stimulated complexes contained activated platelets, whereas small polyanion histone-neutralizing compounds prevented complex generation, linking extracellular histone toxicity to thromboinflammatory and cytopenic phenotypes.

Impact: This study identifies platelet–erythrocyte complexes as a previously underappreciated mechanistic link between extracellular histones and sepsis-associated thrombocytopenia and thrombosis. The prevention of complex formation by small polyanions provides a specific, experimentally testable therapeutic strategy.

Clinical Implications: The findings support further evaluation of histone-neutralizing agents for sepsis-associated coagulopathy, thrombocytopenia, and microvascular thrombosis. They are not yet sufficient to guide clinical treatment, because efficacy, dosing, safety, and benefit in established sepsis remain untested in patients.

Future Directions: Prospective clinical studies should quantify platelet–erythrocyte complexes in sepsis, correlate them with thrombocytopenia, disseminated intravascular coagulation, organ failure, and mortality, and determine whether histone-neutralizing compounds improve outcomes without impairing host defense or hemostasis.

In 329 evaluable episodes, 232 were plasma mNGS-positive and blood-culture-negative, while 53 were positive by both methods. Among dual-positive episodes, only 9.4% had complete species-set concordance; structured blinded clinical review showed that report burden had only a modest association with bloodstream infection likelihood, emphasizing contextual interpretation rather than binary positivity.

Impact: This study directly addresses a major diagnostic challenge created by increasing use of plasma mNGS: distinguishing detection from clinically meaningful bloodstream infection. Its findings provide empirical support for integrating mNGS with clinical assessment and orthogonal microbiology rather than treating mNGS positivity as definitive.

Clinical Implications: Clinicians should interpret plasma mNGS results using signal type, sequence burden, suspected source, contamination risk, and independent microbiologic evidence. The study argues against initiating or narrowing antimicrobial therapy solely on the basis of a binary mNGS result.

Future Directions: Multicenter prospective studies should prespecify interpretation algorithms, evaluate serial mNGS and quantitative thresholds, and measure antimicrobial changes, time to effective therapy, organ failure, mortality, and cost-effectiveness.

Using national Centers for Medicare & Medicaid Services and United States Renal Data System data from 2016–2023, this study quantified Staphylococcus aureus-related sepsis in adults receiving maintenance dialysis. Incidence was 3.3 per 100 patient-years for first events, and central venous catheter use was strongly associated with first-event sepsis compared with arteriovenous fistulas, with an adjusted hazard ratio of 4.24.

Impact: This large national analysis provides contemporary, pandemic-era data on a preventable cause of severe infection in a highly vulnerable population. The strong association with central venous catheters reinforces vascular-access selection as a practical and potentially high-impact prevention target.

Clinical Implications: Dialysis programs should prioritize arteriovenous fistulas or other lower-risk access when clinically feasible, minimize unnecessary CVC exposure, and intensify infection-prevention measures for catheter users and other high-risk subgroups. The findings support quality-improvement and vascular-access interventions but do not by themselves prove that changing access will reduce sepsis.

Future Directions: Future studies should evaluate prospective vascular-access interventions, catheter-removal or replacement strategies, and bundled infection-prevention programs using patient-centered outcomes. Analyses should also examine organism susceptibility, recurrent infection, hospitalization, mortality, and disparities across demographic and clinical subgroups.